Puma Biotechnology Inc
NASDAQ:PBYI

Watchlist Manager
Puma Biotechnology Inc Logo
Puma Biotechnology Inc
NASDAQ:PBYI
Watchlist
Price: 2.99 USD 0.67% Market Closed
Market Cap: 146.7m USD
Have any thoughts about
Puma Biotechnology Inc?
Write Note

Puma Biotechnology Inc
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Puma Biotechnology Inc
Total Receivables Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Puma Biotechnology Inc
NASDAQ:PBYI
Total Receivables
$28.1m
CAGR 3-Years
-3%
CAGR 5-Years
2%
CAGR 10-Years
32%
Abbvie Inc
NYSE:ABBV
Total Receivables
$11.5B
CAGR 3-Years
7%
CAGR 5-Years
16%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Total Receivables
$4.6B
CAGR 3-Years
0%
CAGR 5-Years
7%
CAGR 10-Years
5%
Amgen Inc
NASDAQ:AMGN
Total Receivables
$7.3B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Receivables
$1.8B
CAGR 3-Years
17%
CAGR 5-Years
32%
CAGR 10-Years
31%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Receivables
$6.1B
CAGR 3-Years
4%
CAGR 5-Years
18%
CAGR 10-Years
21%

See Also

What is Puma Biotechnology Inc's Total Receivables?
Total Receivables
28.1m USD

Based on the financial report for Jun 30, 2024, Puma Biotechnology Inc's Total Receivables amounts to 28.1m USD.

What is Puma Biotechnology Inc's Total Receivables growth rate?
Total Receivables CAGR 10Y
32%

Over the last year, the Total Receivables growth was -10%. The average annual Total Receivables growth rates for Puma Biotechnology Inc have been -3% over the past three years , 2% over the past five years , and 32% over the past ten years .

Back to Top